Chest
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: European respiratory society (ERS) guidelines recommend to stratify patients with acute exacerbations of COPD (AECOPD) according to the presence or not of risk factors(RF) for Pseudomonas aeruginosa (PA). There is controversy regarding the need to empirically cover PA in clinical practice. Therefore a better understanding of the prevalence and RF for PA in hospitalized patients with AECOPD is critical in order to appropriately adhere to clinical practice guidelines. Aim: 1) Determine the prevalence of PA pathogens and PA risk RF in hospitalized patients with AECOPD; and 2) Assess the association of PA isolation and PA RF among hospitalized patients with AECOPD. ⋯ The following authors have nothing to disclose: Pedro Marcos, Pilar Sanjuan, Santiago Rodriguez-Segade, Natalia Uribe-Giraldo, Marina Blanco-Aparicio, Isabel Otero, Jorge Ricoy, Hector Verea, Marcos RestrepoNo Product/Research Disclosure Information.
-
Bronchoscopy and Interventional Procedures PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To know about the degree of patients' tolerance of the endobronchial ultrasound (EBUS) using different sedation models. ⋯ The following authors have nothing to disclose: José Ferrando, Iker Fernández-Navamuel, Carmen Centeno Clemente, Pere Vila, Javier Flandes, Felipe Andreo, Andrés Briones, Enrique Cases ViedmaNo Product/Research Disclosure Information.
-
Pediatric Pulmonary Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Portal vein thrombosis is a possible finding in abdominal ultrasound screening on patients with umbilical vein catheterisation, but is uncommon in othervise healthy newborns without intravenous treatment ⋯ Ultrasound screening in neonates, even asymptomatic ones can reveal lifethreating problems that need imediat interventionReference #1: Morag I, Epelman M, Daneman A, et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr. 2006 Jun;148(6):735-9.Reference #2: Isotalo P.A. , Wells G.A., Donnelly J.G. Neonatal and Fetal Methylenetetrahydrofolate Reductase Genetic Polymorphisms: An Examination of C677T and A1298C Mutations. AJHG. 2000Oct.67(4):986-990DISCLOSURE: The following authors have nothing to disclose: Marta Simon, Manuela Cucerea, Delia Tatar, Zsuzsanna Gall, Laura Suciu, Raluca MarianNo Product/Research Disclosure Information.
-
Infectious Disease Case Reports Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Neutropenia complicates the management of critically ill patients. In the absence of malignancy or chemotherapy, its etiology and manifestations can be difficult to identify and portend a poor prognosis. Presented is a case of Neutropenic Enterocolitis (NEC). ⋯ Although a rare complication of medications, neutropenia resulting in NEC is unfortunate and potentially deadly. The case demonstrates the importance of follow up laboratory evaluation by primary care physicians after initiating new pharmacologic therapy.Reference #1: Irvin JD, Viau JM. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. American Journal of Medicine 1986; 81:46-50.Reference #2: Nesher L and Rolston KV. Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy. Clinical Infectious Disease 2013; 56: 711-717.Reference #3: Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986; 57:603-609DISCLOSURE: The following authors have nothing to disclose: Douglas Eddy, Joseph Guileyardo, Adan MoraNo Product/Research Disclosure Information.
-
Diffuse Lung Disease Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Rituximab is used to treat a multitude of malignant and autoimmune conditions. Non-infectious pulmonary complications of rituximab are rare. We present a case of hypersensitivity pneumonitis in a patient treated with rituximab who responded to prednisone. ⋯ The following authors have nothing to disclose: Azzat Ali, Kevin Koehler, Konstantin Shilo, Karen WoodNo Product/Research Disclosure Information.